|Articles|February 8, 2017
USP General Chapters and Reference Standards that Support the Development and Characterization of Biologics
Author(s)Sponsor's Content
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Why Product-Specific Strategies Matter in Advanced Therapy Manufacturing (Part 3)
3
Everything to Know About Cell and Gene Therapy in 2025
4
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
5
